Fundraising Fox株式会社リボミック
Tokyo, JP · 2 known investors
Find your way into 株式会社リボミック
Sign up to see every warm intro you have to 株式会社リボミック
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社リボミック team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ribomic is a company with a U.S. subsidiary engaged in research and development, including pharmaceutical and research-ethics-related activities. The page describes its compliance program, ethics committee, employee training, whistleblower hotline, and management of public research funding.
Founders & leadership
YN
Yoshikazu NakamuraPresident & CEO (代表取締役社長)
Investors · 2
Related companies · 2
Mereo BioPharma GroupMereo BioPharma is a biopharmaceutical company publicly traded on Nasdaq under the ticker MREO. This page presents its share price data and SEC filings for investors and commercial partners.
Ribometrix
Companies working in the same space as 株式会社リボミック.
In the news
Frequently asked questions
- What does 株式会社リボミック do?
- Ribomic is a company with a U.S. subsidiary engaged in research and development, including pharmaceutical and research-ethics-related activities. The page describes its compliance program, ethics committee, employee training, whistleblower hotline, and management of public research funding.
- Who are 株式会社リボミック's investors?
- 株式会社リボミック's investors include Nippon Venture Capital, SMBC Venture Capital.
- Where is 株式会社リボミック headquartered?
- 株式会社リボミック is headquartered in Tokyo, JP.